Citation Impact
Citing Papers
Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World
2006 Standout
Intestinal microbiota in pathophysiology and management of irritable bowel syndrome.
2014
An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori
2000
An evidence-based appraisal of reflux disease management — the Genval Workshop Report
1998
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
2016 Standout
Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification
1999 Standout
Time trends incidence of both major histologic types of esophageal carcinomas in selected countries, 1973–1995
2002
Stability of the irritable bowel syndrome and subgroups as measured by three diagnostic criteria – a 10‐year follow‐up study
2010
The gut mycobiome of the Human Microbiome Project healthy cohort
2017 Standout
Validation of the Rome III Criteria for the Diagnosis of Irritable Bowel Syndrome in Secondary Care
2013
No health without mental health
2007 Standout
Metformin Retards Aging in C. elegans by Altering Microbial Folate and Methionine Metabolism
2013
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis
2008
Functional Bowel Disorders
2006 Standout
Healing and relapse of severe peptic esophagitis after treatment with omeprazole
1988
Epidemiology and Natural History of Gastroparesis
2014
Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis
2015
Functional gastroduodenal disorders
1999
Challenges in managing dyspepsia in general practice
1997
Functional Gastroduodenal Disorders
2006 Standout
Prevalence of organic disease at colonoscopy in patients with symptoms compatible with irritable bowel syndrome: cross-sectional survey
2015
Bowel Disorders
2016 Standout
Risk factors for Barrett’s oesophagus and oesophageal adenocarcinoma: Results from the FINBAR study
2007
Economic evaluation of Helicobacter pylori eradication in the CADET‐Hp randomized controlled trial of H. pylori ‐positive primary care patients with uninvestigated dyspepsia
2004
Prevalence, risk factors and impact of gastroesophageal reflux disease symptoms: A population-based study in South China
2005
Global Cancer Statistics, 2002
2005 Standout
AGA technical review: Evaluation of dyspepsia
1998
Randomised trial of endoscopy with testing for Helicobacter pylori compared with non-invasive H pylori testing alone in the management of dyspepsia
2002
Long-term Outcome of Helicobacter pylori–Negative Idiopathic Bleeding Ulcers: A Prospective Cohort Study
2005
Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis
2010
Identifying intestinal metaplasia at the squamocolumnar junction by using optical coherence tomography
2006
Gastrointestinal symptoms and glycemic control in diabetes mellitus: a longitudinal population study
2008
The Physiology of Gastric Acid Secretion
1988
Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma
2002
Synthesis and Properties of Allenic Natural Products and Pharmaceuticals
2004 Standout
What has happened to the cathartic colon?
1996 Standout
Temporal Trends (1973–1997) in Survival of Patients With Esophageal Adenocarcinoma in The United States: A Glimmer of Hope?
2003
Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics
2017 Standout
The Potential Role of the Dipeptidyl Peptidase-4-Like Activity From the Gut Microbiota on the Host Health
2018
Screening for Barrett’s esophagus in colonoscopy patients with and without heartburn
2003
Management of Barrett's Esophagus: A National Study of Practice Patterns and Their Cost Implications
1999
The Reduction in Colorectal Cancer Mortality After Colonoscopy Varies by Site of the Cancer
2010
Systemic sclerosis
2017 Standout
Pathophysiology and treatment of functional dyspepsia
2004
Esophageal Cancer
2003 Standout
Efficacy of Prebiotics, Probiotics, and Synbiotics in Irritable Bowel Syndrome and Chronic Idiopathic Constipation: Systematic Review and Meta-analysis
2014
Approach to Treatment of Dyspepsia in Primary Care
2003
Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention
2023
Helicobacter Pylori “Test-and-Treat” Strategy for Management of Dyspepsia: A Comprehensive Review
2013
Characterization of the prostanoid receptor profile of enprostil and isomers in smooth muscle and plateletsin vitro
1989
A 12-Week, Randomized, Controlled Trial With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Linaclotide in Irritable Bowel Syndrome With Constipation
2012
Effect of Omeprazole and Ranitidine on Ulcer Healing and Relapse Rates in Patients with Benign Gastric Ulcer
1989
Irritable bowel syndrome
2016 Standout
Guidelines for the Management of Dyspepsia
2005
Tegaserod for the Treatment of Chronic Constipation: A Randomized, Double-Blind, Placebo-Controlled Multinational Study
2005
Adverse Effects of Long-Term Proton Pump Inhibitor Therapy
2011
Global cancer statistics
2011 Standout
The efficacy of proton pump inhibitors in nonulcer dyspepsia: A systematic review and economic analysis
2004
Clinical trial: a randomized trial of early endoscopy, Helicobacter pylori testing and empirical therapy for the management of dyspepsia in primary care
2008
Treating irritable bowel syndrome: overview, perspective and future therapies
2004
Helicobacter pylori-associated diseases
2002
Screening for Celiac Disease in Irritable Bowel Syndrome: An Updated Systematic Review and Meta-analysis
2016
Ulcerative colitis
2012 Standout
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
2004 Standout
Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study
2019 Standout
Relationship between the birth cohort pattern of Helicobacter pylori infection and the epidemiology of duodenal ulcer
2002
What Role Does Helicobacter pylori Play in Dyspepsia and Nonulcer Dyspepsia? Arguments For and Against H. pylori Being Associated With Dyspeptic Symptoms
1997
Oesophageal carcinoma
2013 Standout
Curative endoscopic resection of early esophageal adenocarcinomas (Barrett's cancer)
2006
Gut microbiota role in irritable bowel syndrome: New therapeutic strategies
2016
Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives
2008
Tegaserod for the treatment of irritable bowel syndrome
2004
Fecal Incontinence in Females Older Than Aged 40 Years: Who is at Risk?
2006
Enterochromaffin Cells Are Gut Chemosensors that Couple to Sensory Neural Pathways
2017 StandoutNobel
Systematic review: the efficacy of treatments for irritable bowel syndrome – a European perspective
2006
A comparison of two prostaglandin analogues (enprostil vs misoprostol) in the treatment of acute duodenal ulcer disease
1995
Treatment of irritable bowel syndrome with herbal preparations: results of a double‐blind, randomized, placebo‐controlled, multi‐centre trial
2004
Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma
1999 Standout
The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic
2014 Standout
The challenge of emerging and re-emerging infectious diseases
2004 StandoutNature
Lansoprazole in the treatment of functional dyspepsia: Two Double-Blind, Randomized, Placebo-Controlled trials
2004
The Montreal Definition and Classification of Gastroesophageal Reflux Disease: A Global Evidence-Based Consensus
2006 Standout
Gastrointestinal Toxicity of Nonsteroidal Antiinflammatory Drugs
1999 Standout
Long-Term Survival After Esophagectomy for Barrett's Adenocarcinoma in Endoscopically Surveyed and Nonsurveyed Patients
2002
The Predictive Value of Symptoms in Gastro-oesophageal Reflux Disease
1995
Clinical Guideline: Management of Gastroparesis
2012
Gastric cancer
2020 Standout
Failure of a motilin receptor agonist (ABT‐229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double‐blind placebo‐controlled trial
2000
Meta‐analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome
2001
Helicobacter pyloriInfection
2002 Standout
Gastroesophageal Reflux, Barrett Esophagus, and Esophageal Cancer
2002
Irritable bowel syndrome: Pathogenesis, diagnosis, treatment, and evidence-based medicine
2014
Lack of Effect of TreatingHelicobacter pyloriInfection in Patients with Nonulcer Dyspepsia
1998
The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: the Canadian Adult Dyspepsia Empiric Treatment – Prompt Endoscopy (CADET–PE) study
2003
Current concepts in the management of Helicobacter pylori infection—The Maastricht 2‐2000 Consensus Report
2002
Proton pump inhibitors: update on their role in acid-related gastrointestinal diseases
2005
Management strategies for gastrointestinal, erectile, bladder, and sudomotor dysfunction in patients with diabetes
2011
Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour
2012 Standout
Updated Guidelines 2008 for the Diagnosis, Surveillance and Therapy of Barrett's Esophagus
2008 Standout
Clonal evolution in cancer
2012 StandoutNature
Empirical prescribing for dyspepsia: randomised controlled trial of test and treat versus omeprazole treatment
2003
Bleeding Peptic Ulcer
1994 Standout
The Hallmarks of Aging
2013 Standout
Helicobacter pylori infection in functional dyspepsia
2013
Incidence of Adenocarcinoma among Patients with Barrett's Esophagus
2011
Characteristics of patients with irritable bowel syndrome recruited from three sources: implications for clinical trials
2001
Irritable bowel syndrome subtypes according to bowel habit
2003
Diversity, stability and resilience of the human gut microbiota
2012 StandoutNature
Peptic ulcer disease
2009
Symptom evaluation in reflux disease: workshop background, processes, terminology, recommendations, and discussion outputs
2004
Environmental risk factors in inflammatory bowel diseases. Investigating the hygiene hypothesis: A Spanish case–control study
2010
Continuing Rapid Increase in Esophageal Adenocarcinoma in England and Wales
2008
The prevalence and clinical course of functional dyspepsia
2004
Diagnostic yield of alarm features in irritable bowel syndrome and functional dyspepsia
2004
Risk factors for dyspepsia in a general population: Non-steroidal anti-inflammatory drugs, cigarette smoking and unemployment are more important thanHelicobacter pyloriinfection
2005
Prevalence of and Factors Associated with Fecal Incontinence in a Large Community Study of Older Individuals
2005
Colonoscopic Polypectomy and Long-Term Prevention of Colorectal-Cancer Deaths
2012 Standout
American College of Gastroenterology Monograph on the Management of Irritable Bowel Syndrome and Chronic Idiopathic Constipation
2014
A dose‐ranging, placebo‐controlled, randomized trial of alosetron in patients with functional dyspepsia
2001
A Health Insurance Company–Initiated Multifaceted Intervention for Optimizing Acid-Suppressing Drug Prescriptions in Primary Care
2010
Long term benefits of hypnotherapy for irritable bowel syndrome
2003
Prevalence of Symptomatic Pelvic Floor Disorders in US Women
2008 Standout
Sustained benefit from intravenous immunoglobulin therapy for gastrointestinal involvement in systemic sclerosis
2015
Helicobacter pylori “Test and Treat” or Endoscopy for Managing Dyspepsia: An Individual Patient Data Meta-analysis
2005
Efficacy of alosetron in irritable bowel syndrome: a meta‐analysis of randomized controlled trials
2003
Risk of Gastroparesis in Subjects With Type 1 and 2 Diabetes in the General Population
2011
Risk factors for Barrett's esophagus: A case‐control study
2001
Prevalence of acid reflux in functional dyspepsia and its association with symptom profile
2005
Intestinal microbiota in functional bowel disorders: a Rome foundation report
2012
Irritable Bowel Syndrome
2015 Standout
Gastroesophageal Reflux Disease
1996
Are the definitions for chronic diarrhoea adequate? Evaluation of two different definitions in patients with chronic diarrhoea
2015
Self-Reported Gastrointestinal Symptoms in Type 2 Diabetes Improve With an Intensive Lifestyle Intervention: Results From the Action for Health in Diabetes (Look AHEAD) Clinical Trial
2015
Audit and feedback: effects on professional practice and healthcare outcomes
2012 Standout
Plasma Cytokine Profiles in Females With Irritable Bowel Syndrome and Extra-Intestinal Co-Morbidity
2010
Comparison of inter- and intraobserver consistency for grading of esophagitis by expert and trainee endoscopists
2002
Diabetic Neuropathies
2005 Standout
Surveillance and survival in Barrett's adenocarcinomas: A population-based study
2002
Dialogue between E. coli free radical pathways and the mitochondria of C. elegans
2015 StandoutNobel
Cost effectiveness of initial endoscopy for dyspepsia in patients over age 50 years: a randomised controlled trial in primary care
2000
Diabetic Gastroparesis
2007
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
A Survey of Canadian Gastroenterologists about the Management of Barrett’s Esophagus
2003
The role of endoscopy in dyspepsia
2007
Quality Indicators for Colonoscopy
2006
Depression Increases Diabetes Symptoms by Complicating Patients’ Self-Care Adherence
2004
An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori. Canadian Dyspepsia Working Group.
2000
Pathogenesis ofHelicobacter pyloriInfection
2006 Standout
Spermidine in health and disease
2018 StandoutScience
Twelve-month endoscopic and histological analysis following proton-pump inhibitor-based triple therapy inHelicobacter pylori-positive patients with gastric ulcers
2010
The Stool Antigen Test for Detection of Helicobacter pylori after Eradication Therapy
2002
Oxidative Stress: An Essential Factor in the Pathogenesis of Gastrointestinal Mucosal Diseases
2014 Standout
Proton pump inhibitors and risk of vitamin and mineral deficiency: evidence and clinical implications
2013
Molecular analysis of the luminal- and mucosal-associated intestinal microbiota in diarrhea-predominant irritable bowel syndrome
2011
Endoscopic Grading of Reflux Oesophagitis: What Observations Correlate with Gastro-Oesophageal Reflux?
1997
Canadian Consensus Conference on the Management of Gastroesophageal Reflux Disease in Adults – Update 2004
2005
Iron-Deficiency Anemia
2015 Standout
Prevalence of Delayed Gastric Emptying in Diabetic Patients and Relationship to Dyspeptic Symptoms
2003
Diabetic Neuropathy: A Position Statement by the American Diabetes Association
2016 Standout
Systematic review: probiotics in the management of lower gastrointestinal symptoms in clinical practice - an evidence-based international guide
2013
Epidemiology of Adenocarcinoma of the Esophagus, Gastric Cardia, and Upper Gastric Third
2009
A Canadian Physician Survey of Dyspepsia Management
1998
Placebo-Controlled Trial of Cisapride and Nizatidine in Unselected Patients With Functional Dyspepsia
1998
Autonomic Symptoms and Diabetic Neuropathy
2004
Evidence-Based Recommendations for Short- and Long-Term Management of Uninvestigated Dyspepsia in Primary Care: An Update of the Canadian Dyspepsia Working Group (CanDys) Clinical Management Tool
2005
Cost-Effectiveness of Population Screening for Helicobacter Pylori in Preventing Gastric Cancer and Peptic Ulcer Disease, Using Simulation
2003
Inflammatory Exposure and Historical Changes in Human Life-Spans
2004 StandoutScience
Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features, and Rome IV
2016 Standout
Probiotic Therapy of the Irritable Bowel Syndrome: Why Is the Evidence Still Poor and What Can Be Done About It?
2015
Review article: probiotics for the treatment of irritable bowel syndrome – focus on lactic acid bacteria
2012
Mutation of the gastric hydrogen-potassium ATPase alpha subunit causes iron-deficiency anemia in mice
2011 StandoutNobel
Works of Peter Bytzer being referenced
Controlled trial of arbaprostil in bleeding peptic ulcer.
1985
Enprostil and ranitidine in duodenal ulcer healing: double blind comparative trial.
1986
Impact of chronic gastrointestinal symptoms in diabetes mellitus on health-related quality of life
2001
Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease
2001
Oral hypoglycaemic drugs and gastrointestinal symptoms in diabetes mellitus
2001
Patients Suspected of Irritable Bowel Syndrome—Cross-Sectional Study Exploring the Sensitivity of Rome III Criteria in Primary Care
2013
The Prevalence of Intestinal Parasites Is Not Greater Among Individuals With Irritable Bowel Syndrome: A Population-based Case-control Study
2014
Accuracy of the diagnosis of GORD by questionnaire, physicians and a trial of proton pump inhibitor treatment: the Diamond Study
2010
Helicobacter pylori –Negative Duodenal Ulcers: Prevalence, Clinical Characteristics, and Prognosis—Results From a Randomized Trial With 2-Year Follow-Up
2001
H 2 receptor antagonists and prokinetics in dyspepsia: a critical review
2002
Prevalence of Gastrointestinal Symptoms Associated With Diabetes Mellitus
2001
Interobserver Variation in the Endoscopic Diagnosis of Reflux Esophagitis
1993
Identifying responders to acid suppression in dyspepsia using a random starting day trial
2000
The Incidence of Adenocarcinoma and Squamous Cell Carcinoma of the Esophagus: Barrett's Esophagus Makes a Difference
2005
Aetiology, Medical History, and Faecal Weight in Adult Patients Referred for Diarrhoea: A Prospective Survey
1990
Irritable bowel syndrome: The burden and unmet needs in Europe
2006
Gi Symptoms in Diabetes Mellitus Are Associated With Both Poor Glycemic Control and Diabetic Complications
2002
Clinical trial guidelines for pharmacological treatment of irritable bowel syndrome
2003
Clinical trial: the glucagon‐like peptide‐1 analogue ROSE‐010 for management of acute pain in patients with irritable bowel syndrome: a randomized, placebo‐controlled, double‐blind study
2008
Placebo-Controlled Trial of Cisapride and Nizatidine in Unselected Patients With Functional Dyspepsia
1998
Effects of probiotic fermented milk on symptoms and intestinal flora in patients with irritable bowel syndrome: A randomized, placebo-controlled trial
2011
Helicobacter pylori test-and-eradicate versus prompt endoscopy for management of dyspeptic patients: a randomised trial
2000
Endoscopic Follow-up Study of Gastric Ulcer to Detect Malignancy: Is It Worthwhile?
1991
Menetrier's Disease and Helicobacter pylori (Normalization of Gastrointestinal Protein Loss After Eradication Therapy)
1999
Screening for drug related dyspepsia
1998
Management issues in dyspepsia: current consensus and controversies
2004
Effect of omeprazole and cimetidine on prepyloric gastric ulcer: double blind comparative trial.
1988
Characteristics of Acute Pain Attacks in Patients With Irritable Bowel Syndrome Meeting Rome III Criteria
2011
Appropriateness of colonoscopy in Europe (EPAGE II) – Screening for colorectal cancer
2009
Empirical H2-blocker therapy or prompt endoscopy in management of dyspepsia
1994
Treatment of Helicobacter pylori
2005
Oral supplementation of healthy adults with 2′-O-fucosyllactose and lacto-N-neotetraose is well tolerated and shifts the intestinal microbiota
2016
A Positive Diagnostic Strategy Is Noninferior to a Strategy of Exclusion for Patients With Irritable Bowel Syndrome
2013
Proton-Pump Inhibitor Therapy Induces Acid-Related Symptoms in Healthy Volunteers After Withdrawal of Therapy
2009
Predicting Endoscopic Diagnosis in the Dyspeptic Patient: The Value of Predictive Score Models
1997
Adenocarcinoma of the Esophagus and Barrett's Esophagus: A Population-Based Study
1999
Six‐month trial of on‐demand rabeprazole 10 mg maintains symptom relief in patients with non‐erosive reflux disease
2004
Predicting endoscopie diagnosis in the dyspeptic patient
1996
On-demand therapy for gastro-oesophageal reflux disease.
2001
Diagnosing dyspepsia: Any controversies left?
1996
Prevalence of surreptitious laxative abuse in patients with diarrhoea of uncertain origin: a cost benefit analysis of a screening procedure.
1989
Design of treatment trials for functional gastrointestinal disorders
1999
Diagnosis and treatment of Helicobacter pylori infection.
2011
Psychological Distress Is Linked To Gastrointestinal Symptoms in Diabetes Mellitus
2001
Goals of Therapy and Guidelines for Treatment Success in Symptomatic Gastroesophageal Reflux Disease Patients
2003
Effect of Omeprazole and Cimetidine on Duodenal Ulcer
1985
Short‐term stability of subtypes in the irritable bowel syndrome: prospective evaluation using the Rome III classification
2011
Adenocarcinoma of the esophagus and Barrett's esophagus: a population-based study
1999
Enprostil and ranitidine in prevention of duodenal ulcer relapse: one year double blind comparative trial.
1987
The Value of Alarm Features in Identifying Organic Causes of Dyspepsia
2000
Symptom clustering in subjects with and without diabetes mellitus: a population-based study of 15,000 Australian adults
2003
[Drug therapy of non-ulcer dyspepsia].
1991
Low socioeconomic class is a risk factor for upper and lower gastrointestinal symptoms: a population based study in 15 000 Australian adults
2001
Dyspepsia
2001
Prediction of Major Pathologic Conditions in Dyspeptic Patients Referred for Endoscopy: A Prospective Validation Study of a Scoring System
1992
On-Demand Therapy for Gastroesophageal Reflux Disease
2006